• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伐昔洛韦和泛昔洛韦治疗带状疱疹的疗效:一项对比研究。

Efficacy of valacyclovir and famciclovir in herpes zoster: A comparative study.

机构信息

Assistant Professor, Department of Pharmacology, ACS Medical College, Chennai, Tamil Nadu, India.

Assistant Professor, Department of Pharmacology, BRIMS, Bidar, Karnataka, India.

出版信息

Indian J Pharmacol. 2020 Nov-Dec;52(6):472-475. doi: 10.4103/ijp.IJP_555_18.

DOI:10.4103/ijp.IJP_555_18
PMID:33666187
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8092181/
Abstract

OBJECTIVES

The objective was to evaluate the efficacy of antiviral agent valacyclovir compared with famciclovir in the treatment of herpes zoster.

MATERIALS AND METHODS

A comparative study was conducted over a period of 1 year. Data relevant to the study were collected from 60 patients, with active herpes zoster presenting to the outpatient department within 72 hr of the first occurrence of zoster rash. They were divided in to two groups of 30 patients each. The first group of patients received valacyclovir tablet 1000 mg thrice daily, whereas those in the second group were given famciclovir tablet 500 mg thrice daily. Both the drugs were given for 7 days. Periodic follow-up till 29 day was done for assessment of the effects of given drugs.

RESULTS

Significant decrease was observed on comparison of pain scores between the two groups using the visual analog scale, with the drug valacyclovir, than in the famciclovir group at day 29. Furthermore, valacyclovir treatment accelerated the resolution of zoster associated pain in more number of patients compared with famciclovir.

CONCLUSION

Oral valacyclovir administered during acute zoster infection for a period of 7 days offers significant benefit compared to famciclovir by providing a well tolerated and greater resolution of pain while maintaining the favorable safety profile, making valacyclovir more efficacious and a better drug in management of Herpes Zoster in comparison to famciclovir.

摘要

目的

评估抗病毒药物伐昔洛韦与泛昔洛韦治疗带状疱疹的疗效。

材料和方法

进行了为期 1 年的对比研究。从在带状疱疹皮疹首次出现后 72 小时内到门诊就诊的 60 名活动性带状疱疹患者中收集了与研究相关的数据。他们分为两组,每组 30 名患者。第一组患者每天服用伐昔洛韦片 1000 毫克,分三次服用,而第二组患者每天服用泛昔洛韦片 500 毫克,分三次服用。两种药物均使用 7 天。进行定期随访至 29 天,以评估给予药物的效果。

结果

使用视觉模拟量表比较两组的疼痛评分,伐昔洛韦组在第 29 天的疼痛评分显著低于泛昔洛韦组。此外,伐昔洛韦治疗组与泛昔洛韦治疗组相比,更多患者的带状疱疹相关疼痛得到更快缓解。

结论

在急性带状疱疹感染期间,使用伐昔洛韦治疗 7 天,与泛昔洛韦相比,提供了显著的益处,通过提供更耐受和更有效的疼痛缓解,同时保持良好的安全性,使伐昔洛韦在管理带状疱疹方面比泛昔洛韦更有效和更好的药物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7310/8092181/b9bb8ee4e7cf/IJPharm-52-472-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7310/8092181/21c82a0be439/IJPharm-52-472-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7310/8092181/1f0ebd251a10/IJPharm-52-472-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7310/8092181/b9bb8ee4e7cf/IJPharm-52-472-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7310/8092181/21c82a0be439/IJPharm-52-472-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7310/8092181/1f0ebd251a10/IJPharm-52-472-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7310/8092181/b9bb8ee4e7cf/IJPharm-52-472-g003.jpg

相似文献

1
Efficacy of valacyclovir and famciclovir in herpes zoster: A comparative study.伐昔洛韦和泛昔洛韦治疗带状疱疹的疗效:一项对比研究。
Indian J Pharmacol. 2020 Nov-Dec;52(6):472-475. doi: 10.4103/ijp.IJP_555_18.
2
Comparison between famciclovir and valacyclovir for acute pain in adult Japanese immunocompetent patients with herpes zoster.泛昔洛韦与伐昔洛韦治疗成人日本免疫功能正常的带状疱疹急性疼痛的比较。
J Dermatol. 2012 Nov;39(11):902-8. doi: 10.1111/j.1346-8138.2012.01584.x. Epub 2012 Jun 1.
3
Comparison of Famciclovir, Valaciclovir, and Brivudine Treatments in Adult Immunocompetent Patients With Herpes Zoster.泛昔洛韦、伐昔洛韦和溴夫定治疗成人免疫功能正常的带状疱疹患者的比较。
Am J Ther. 2018 Nov/Dec;25(6):e626-e634. doi: 10.1097/MJT.0000000000000436.
4
Antiviral therapy for herpes zoster: randomized, controlled clinical trial of valacyclovir and famciclovir therapy in immunocompetent patients 50 years and older.带状疱疹的抗病毒治疗:50岁及以上免疫功能正常患者使用伐昔洛韦和泛昔洛韦治疗的随机对照临床试验
Arch Fam Med. 2000 Sep-Oct;9(9):863-9. doi: 10.1001/archfami.9.9.863.
5
A Network Meta-Analysis of Randomized Clinical Trials to Assess the Efficacy and Safety of Antiviral Agents for Immunocompetent Patients with Herpes Zoster-Associated Pain.一项网状荟萃分析评估抗病毒药物治疗免疫功能正常的带状疱疹相关性疼痛患者的疗效和安全性的随机临床试验。
Pain Physician. 2023 Jul;26(4):337-346.
6
Valacyclovir in the treatment of herpes simplex, herpes zoster, and other viral infections.伐昔洛韦在单纯疱疹、带状疱疹及其他病毒感染治疗中的应用。
J Cutan Med Surg. 2003 Sep-Oct;7(5):372-81. doi: 10.1007/s10227-002-0140-3. Epub 2003 Sep 24.
7
Efficacy of famciclovir in the treatment of herpes zoster.泛昔洛韦治疗带状疱疹的疗效。
Semin Dermatol. 1996 Jun;15(2 Suppl 1):27-31.
8
Open-label study of valacyclovir 1.5 g twice daily for the treatment of uncomplicated herpes zoster in immunocompetent patients 18 years of age or older.一项关于伐昔洛韦每日两次、每次1.5克用于治疗18岁及以上免疫功能正常患者的非复杂性带状疱疹的开放标签研究。
J Cutan Med Surg. 2007 May-Jun;11(3):89-98. doi: 10.2310/7750.2007.00016.
9
Herpes zoster guideline of the German Dermatology Society (DDG).德国皮肤病学会(DDG)带状疱疹指南。
J Clin Virol. 2003 Apr;26(3):277-89; discussion 291-3. doi: 10.1016/s1386-6532(03)00005-2.
10
Brivudin compared with famciclovir in the treatment of herpes zoster: effects in acute disease and chronic pain in immunocompetent patients. A randomized, double-blind, multinational study.与泛昔洛韦相比,溴夫定治疗带状疱疹:对免疫功能正常患者急性疾病和慢性疼痛的影响。一项随机、双盲、多国研究。
J Eur Acad Dermatol Venereol. 2005 Jan;19(1):47-55. doi: 10.1111/j.1468-3083.2004.01119.x.

引用本文的文献

1
Herpes zoster after left nephroureterectomy for renal carcinoma: a case report.左肾癌行肾输尿管切除术后发生带状疱疹:一例报告
BMC Infect Dis. 2025 Jan 14;25(1):62. doi: 10.1186/s12879-025-10460-1.

本文引用的文献

1
Herpes Zoster and Postherpetic Neuralgia: Practical Consideration for Prevention and Treatment.带状疱疹及带状疱疹后神经痛:预防与治疗的实际考量
Korean J Pain. 2015 Jul;28(3):177-84. doi: 10.3344/kjp.2015.28.3.177. Epub 2015 Jul 1.
2
Systematic review of incidence and complications of herpes zoster: towards a global perspective.带状疱疹发病率及并发症的系统评价:全球视角
BMJ Open. 2014 Jun 10;4(6):e004833. doi: 10.1136/bmjopen-2014-004833.
3
Comparison between famciclovir and valacyclovir for acute pain in adult Japanese immunocompetent patients with herpes zoster.
泛昔洛韦与伐昔洛韦治疗成人日本免疫功能正常的带状疱疹急性疼痛的比较。
J Dermatol. 2012 Nov;39(11):902-8. doi: 10.1111/j.1346-8138.2012.01584.x. Epub 2012 Jun 1.
4
Diagnosis and assessment of pain associated with herpes zoster and postherpetic neuralgia.带状疱疹及带状疱疹后神经痛相关疼痛的诊断与评估
J Pain. 2008 Jan;9(1 Suppl 1):S37-44. doi: 10.1016/j.jpain.2007.10.008.
5
Epidemiology and burden of herpes zoster and post-herpetic neuralgia in Australia, Asia and South America.澳大利亚、亚洲和南美洲带状疱疹及带状疱疹后神经痛的流行病学与负担
Herpes. 2007 Sep;14 Suppl 2:40-4.
6
Herpes zoster.带状疱疹
BMJ. 2007 Jun 9;334(7605):1211-5. doi: 10.1136/bmj.39206.571042.AE.
7
Varicella.水痘
Lancet. 2006 Oct 14;368(9544):1365-76. doi: 10.1016/S0140-6736(06)69561-5.
8
Comparative efficacy of famciclovir and valacyclovir for suppression of recurrent genital herpes and viral shedding.泛昔洛韦和伐昔洛韦对复发性生殖器疱疹抑制及病毒排出的疗效比较
Sex Transm Dis. 2006 Sep;33(9):529-33. doi: 10.1097/01.olq.0000204723.15765.91.
9
What does epidemiology tell us about risk factors for herpes zoster?流行病学能告诉我们关于带状疱疹的危险因素有哪些?
Lancet Infect Dis. 2004 Jan;4(1):26-33. doi: 10.1016/s1473-3099(03)00857-0.
10
Antiviral therapy for herpes zoster: randomized, controlled clinical trial of valacyclovir and famciclovir therapy in immunocompetent patients 50 years and older.带状疱疹的抗病毒治疗:50岁及以上免疫功能正常患者使用伐昔洛韦和泛昔洛韦治疗的随机对照临床试验
Arch Fam Med. 2000 Sep-Oct;9(9):863-9. doi: 10.1001/archfami.9.9.863.